Johnson & Johnson (US.JNJ)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.JNJ · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 78.7% | ↑ |
| ROE | 12.7% | ↓ |
| Cash Conversion | 103.4% | ↑ |
| D/E Ratio | 0.58 | ↑ |
| Gross Margin | 67.3% | → |
US.JNJ (Johnson & Johnson) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 78.7% ↑ ROE 12.7% ↓ Cash Conversion 103.4% ↑ D/E Ratio 0.58 ↑ Gross Margin 67.3% →
Key Metrics
US.JNJ (Johnson & Johnson) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 78.7% ↑ROE 12.7% ↓Cash Conversion 103.4% ↑D/E Ratio 0.58 ↑Gross Margin 67.3% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies